Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Codexis Inc (CDXS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Codexis (CDXS) Reports Break-Even Earnings for Q3

Codexis (CDXS) delivered earnings and revenue surprises of 100.00% and 15.81%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

CDXS : 17.00 (-2.24%)
Codexis: 3Q Earnings Snapshot

REDWOOD CITY, Calif. (AP) _ Codexis Inc. (CDXS) on Thursday reported a loss of $2 million in its third quarter.

CDXS : 17.00 (-2.24%)
Codexis Reports Third Quarter 2018 Financial Results

Total revenues increase 70% to $16.9 million driven by higher product revenue and R&D revenue across an increased number of customers

CDXS : 17.00 (-2.24%)
Codexis Announces Results of Phase 1a Clinical Trial with CDX-6114

CDX-6114 meets safety and tolerability endpoints

CDXS : 17.00 (-2.24%)
Codexis to Present at Two Investment Conferences in November

Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will present at two upcoming investment conferences:

CDXS : 17.00 (-2.24%)
Will Codexis (CDXS) Report Negative Earnings Next Week? What You Should Know

Codexis (CDXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CDXS : 17.00 (-2.24%)
Investor Expectations to Drive Momentum within Arsanis, Dynavax Technologies, Puma Biotechnology, Opko Health, Adaptimmune Therapeutics, and Codexis -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Arsanis, Inc. (NASDAQ:ASNS),...

CDXS : 17.00 (-2.24%)
PBYI : 25.22 (-0.98%)
ASNS : 3.20 (-4.19%)
DVAX : 12.05 (-0.33%)
OPK : 3.80 (+2.15%)
ADAP : 4.86 (-3.57%)
Codexis Appoints Claus Ladefoged to Global Enzyme Business Development Role

Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces the appointment of Claus Ladefoged as Director, Enzyme Business Development. Ladefoged has extensive experience in successfully...

CDXS : 17.00 (-2.24%)
NVO : 48.05 (+0.84%)
Guest Host Tonight

Guest Host Tonight

CDXS : 17.00 (-2.24%)
WK : 38.22 (+1.19%)
MLAB : 216.05 (+0.02%)
Cimpress Aims to Mitigate Risks by Decentralizing Operations

Cimpress' (CMPR) management has decentralized operations to improve accountability for customer satisfaction and capital returns, simplify decision-making and improve the speed of execution.

CMPR : 119.99 (+0.12%)
CDXS : 17.00 (-2.24%)
KIGRY : 13.6600 (+3.17%)
HDS : 40.03 (+1.14%)
Here's Why You Should Add Sonoco (SON) to Your Portfolio Now

Sonoco's (SON) prospects remain bright on the back of solid earnings estimate revision activity as well as an upbeat guidance.

SON : 54.81 (+0.48%)
CDXS : 17.00 (-2.24%)
AOS : 48.01 (+3.29%)
IEX : 140.77 (+2.13%)
Codexis: 1Q Earnings Snapshot

REDWOOD CITY, Calif. (AP) _ Codexis Inc. (CDXS) on Thursday reported a loss of $4.7 million in its first quarter.

CDXS : 17.00 (-2.24%)
Codexis Reports First Quarter 2018 Financial Results

Total revenues increase 76% to $14.0 million on sharply higher R&D revenue

CDXS : 17.00 (-2.24%)
Porton Pharma Solutions and Codexis Launch Global Partnership

Codexis, Inc. (NASDAQ: CDXS) and Porton Pharma Solutions, Ltd. (SZSE: 300363) announce a strategic collaboration to deploy Codexis' world-leading biocatalyst technology within...

CDXS : 17.00 (-2.24%)
EnzymeWorks, Inc. Retracts Prior Press Release

EnzymeWorks has been ordered by the United States District Court for the Northern District of California to retract its prior statements and press releases pertaining in any way to the settlement...

CDXS : 17.00 (-2.24%)
New Research Coverage Highlights Alliance Resource Partners, MyoKardia, Pan American Silver, Stitch Fix, Codexis, and Chemical Financial -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Alliance Resource Partners,...

CDXS : 17.00 (-2.24%)
SFIX : 22.92 (+7.30%)
PAAS : 14.18 (-2.14%)
ARLP : 18.45 (+0.99%)
MYOK : 45.52 (+1.88%)
CHFC : 43.64 (+2.92%)
Codexis Announces Pricing of Public Offering of Common Stock

Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 3,750,000 shares of its common stock at a public offering price of...

CDXS : 17.00 (-2.24%)
Codexis Announces Proposed Public Offering of Common Stock

Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to be sold in...

CDXS : 17.00 (-2.24%)
Codexis to Present at H.C. Wainwright Global Life Sciences Conference in Monte Carlo, Monaco

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at the H.C. Wainwright Global Life Sciences Conference on Tuesday, April 10, 2018 at 9:50 a.m....

CDXS : 17.00 (-2.24%)
Origenis Appoints Dr. Peter Seufer-Wasserthal as Chief Business Officer

Origenis GmbH, a German biotech company specializing in the discovery and development of highly selective small molecule kinase inhibitors for CNS disorders, today announced the appointment...

CDXS : 17.00 (-2.24%)
XON : 8.83 (+4.99%)

Van Meerten Stock Picks

Intelligent Systems - Pick of the Day
My Pick of the Day belongs to the technology service company Intelligent Systems (INS).
INS +1.54
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar